Lansoprazole Structural Formula (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 01)
Lansoprazole
Product Images NDC 42254-227
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 42254-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 02)
This text describes a chart representing the mean severity of day heartburn over the course of the treatment. The treatments included placebo, and two different dosages of lansoprazole (15 mg QD and 30 mg QD). The chart displays the severity measurements on the Y-axis and the days from start of treatment on the X-axis.*
Figure 2 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 03)
Lansoprazole 30mg (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 04)
This is a description of a medication called Lansoprazole 30mg. It appears to be packaged in capsules and is available through a pharmaceutical company called Teva. The packaging company is Physician Partner and it advises the medication be stored at room temperature. However, the text does not provide a detailed description of the medication's uses or side-effects.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
